Clin Oncol (R Coll Radiol) 2017 Nov 16
Oligoprogressive Oncogene-addicted Lung Tumours: Does Stereotactic Body Radiotherapy Have a Role? Introducing the HALT Trial.
Related Questions
Would you consider SBRT and continue osimertinib?
New answer by Medical Oncologist at Georgetown University Hospital (April 29, 2021)
If osimertinib is effective at all other sites of disease (and has been well tolerated), local therapy to an isolated site of progression is an appealing option. SBRT or other...